To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed Sensei Biotherapeutics sets IPO pricing terms
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, has priced its over 5.8 million shares between $16 and $18 per share.
